Peroxisomal D-hydroxyacyl-CoA dehydrogenase deficiency: resolution of the enzyme defect and its molecular basis in bifunctional protein deficiency.
Peroxisomes play an essential role in a number of different metabolic pathways, including the beta-oxidation of a distinct set of fatty acids and fatty acid derivatives. The importance of the peroxisomal beta-oxidation system in humans is made apparent by the existence of a group of inherited diseases in which peroxisomal beta-oxidation is impaired. This includes X-linked adrenoleukodystrophy and other disorders with a defined defect. On the other hand, many patients have been described with a defect in peroxisomal beta-oxidation of unknown etiology. Resolution of the defects in these patients requires the elucidation of the enzymatic organization of the peroxisomal beta-oxidation system. Importantly, a new peroxisomal beta-oxidation enzyme was recently described called D-bifunctional protein with enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase activity primarily reacting with alpha-methyl fatty acids like pristanic acid and di- and trihydroxycholestanoic acid. In this patient we describe the first case of D-bifunctional protein deficiency as resolved by enzyme activity measurements and mutation analysis. The mutation found (Gly16Ser) is in the dehydrogenase coding part of the gene in an important loop of the Rossman fold forming the NAD+-binding site. The results show that the newly identified D-bifunctional protein plays an essential role in the peroxisomal beta-oxidation pathway that cannot be compensated for by the L-specific bifunctional protein.
van Grunsven
E G
EG
University of Amsterdam, Academic Medical Centre, Department of Clinical Chemistry, Laboratory of Genetic Metabolic Diseases, Amsterdam, The Netherlands.
van Berkel
E
E
Ijlst
L
L
Vreken
P
P
de Klerk
J B
JB
Adamski
J
J
Lemonde
H
H
Clayton
P T
PT
Cuebas
D A
DA
Wanders
R J
RJ
D015067:17-Hydroxysteroid Dehydrogenases; D015094:3-Hydroxyacyl CoA Dehydrogenases / Q000172:deficiency* / Q000235:genetics; D000015:Abnormalities, Multiple / Q000201:enzymology* / Q000235:genetics; D001483:Base Sequence; D001665:Binding Sites; D001921:Brain / Q000002:abnormalities / Q000473:pathology; D002478:Cells, Cultured; D017931:DNA Primers; D004746:Enoyl-CoA Hydratase; D017809:Fatal Outcome; D005260:Female; D005998:Glycine; D006801:Humans; D006836:Hydro-Lyases / Q000172:deficiency* / Q000235:genetics; D007223:Infant; D008279:Magnetic Resonance Imaging; D008297:Male; D008830:Microbodies / Q000201:enzymology; D009097:Multienzyme Complexes / Q000172:deficiency* / Q000235:genetics; D064029:Peroxisomal Multifunctional Protein-2; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D012694:Serine; D012867:Skin / Q000201:enzymology
D017931:DNA Primers; D009097:Multienzyme Complexes; D012694:Serine; D015067:17-Hydroxysteroid Dehydrogenases; D015094:3-Hydroxyacyl CoA Dehydrogenases; D006836:Hydro-Lyases; D064029:Peroxisomal Multifunctional Protein-2; C104587:HSD17B4 protein, human; D004746:Enoyl-CoA Hydratase; D005998:Glycine